For families facing childhood cancer, access to advanced medical technology can make an enormous difference during an already difficult journey. Hyundai Canada and its nationwide network of 225 dealerships are helping strengthen pediatric cancer care in Hamilton with a $100,000 donation to McMaster Children’s Hospital. Announced on October 14, 2026, through Hyundai Hope on Wheels, the contribution will support a multimillion-dollar campaign to bring advanced imaging equipment to the hospital. The announcement was inspired by 10-year-old cancer survivor Bennett, whose treatment involved chemotherapy, radiation, and surgery after doctors discovered a large tumour near his ribs. With a national fundraising commitment exceeding $4.1 million this year, Hyundai’s initiative is connecting Canadian automotive dealerships with hospitals, researchers, and families working toward better outcomes for children with cancer.
Hyundai’s $100,000 Gift Will Support Advanced Cancer Imaging
Hyundai Hope on Wheels announced the $100,000 contribution on October 14, directing the funding to MacKids, the fundraising initiative supporting McMaster Children’s Hospital. The donation will help advance a $3-million campaign to bring an Alpha Photon-Counting Computed Tomography scanner to the hospital. This next-generation CT system is designed to produce clearer diagnostic images while reducing radiation exposure. For children undergoing cancer treatment, including those requiring repeated examinations, those improvements could make a meaningful difference in how doctors investigate symptoms and monitor disease.
The announcement is particularly significant because the donation supports a specific medical technology project rather than an unrestricted hospital operating fund. Hamilton Health Sciences Foundation is seeking contributions to replace aging imaging equipment and improve diagnostic capacity for children across the region. The proposed scanner could help physicians identify abnormalities, monitor responses to treatment, and make clinical decisions using more detailed images. Although Hyundai’s contribution represents only one part of the total fundraising requirement, it brings the hospital closer to acquiring equipment that could benefit thousands of patients annually. The investment also supports a broader effort to make advanced pediatric care available closer to families’ homes.
A Young Cancer Survivor’s Journey Helped Inspire the Donation
Behind the announcement is the story of Bennett, a Hamilton-area child whose experience demonstrates why better diagnostic imaging matters. Around his sixth birthday, Bennett arrived at McMaster Children’s Hospital after developing symptoms that initially resembled the flu. Further examination revealed something far more serious: a tumour approximately the size of a baseball growing from one of his ribs. Doctors diagnosed Ewing sarcoma, a rare form of cancer that primarily affects bones or surrounding soft tissue. For Bennett’s parents, Scott and Katelyn, what began as concern over an apparently ordinary childhood illness suddenly became an entirely different reality.
Bennett’s treatment involved 14 rounds of chemotherapy, 32 days of radiation therapy, surgery, and numerous medical procedures. His family has described the experience as exhausting and frightening, while also highlighting his remarkable optimism throughout treatment. Now 10 years old, Bennett is in remission and doing well. His mother and brother joined him at Hyundai’s Hamilton Handprint Ceremony, where his experience helped put a human face on the donation. His recovery is encouraging, although remission does not eliminate the importance of ongoing medical monitoring. For families facing similar diagnoses, the possibility of faster examinations and reduced radiation exposure offers another reason to support improved imaging technology.
The New CT Scanner Could Reduce Radiation Exposure for Children
The technology at the centre of Hyundai’s donation works differently from conventional computed tomography. Traditional CT equipment measures the accumulated energy of incoming X-rays, while photon-counting systems detect individual X-ray photons and their energy characteristics. This approach can improve image resolution and reduce electronic noise, potentially helping physicians distinguish small structures or abnormalities more clearly. Hamilton Health Sciences Foundation says the proposed Alpha PCCT scanner could reduce radiation exposure by approximately 40% under some conditions and by as much as 80% in certain applications.
Independent medical research offers support for the technology’s potential, although results depend on the examination and imaging settings. A 2026 systematic review published in Pediatric Radiology examined 12 comparative studies involving 1,545 study-arm observations or examinations. Researchers found that photon-counting CT was associated with lower radiation-dose measures and improvements in objective image quality compared with conventional CT systems. However, the review also identified variation between examinations and limitations in predicting clinical benefits across different settings. For pediatric oncology patients, the opportunity is especially important because repeated scans may be necessary over several years. Reducing cumulative exposure while maintaining useful diagnostic information could provide long-term benefits without compromising the quality of medical decisions.
McMaster Children’s Hospital Hopes to Install the Scanner by Spring 2027
The proposed Alpha PCCT scanner is part of a fundraising campaign with a $3-million target. Hyundai’s $100,000 contribution will help finance that larger effort, while Hamilton Health Sciences Foundation continues seeking support from individuals, businesses, and other donors. According to Hyundai’s October announcement, McMaster Children’s Hospital hopes to have the equipment installed by spring 2027. The hospital has not confirmed that installation is guaranteed by that date, and the fundraising campaign does not establish that every procurement or commissioning requirement has been completed.
The importance of the project extends beyond pediatric cancer. Hospital officials expect the scanner to support diagnostic imaging for children with complex heart conditions and other serious illnesses, as well as certain adult patients. Hamilton Health Sciences Foundation estimates that thousands of patients could benefit from the equipment each year. The organization also notes that existing CT resources face increasing demand, placing additional pressure on aging technology. Dr. John Donnellan, Hamilton Health Sciences’ chief of diagnostic imaging, has described the project as a potentially transformative advancement in regional pediatric imaging. For families, the proposed benefits are practical rather than purely technical: clearer answers, potentially shorter procedures, and the possibility of fewer examinations requiring sedation. Those outcomes will ultimately depend on how the scanner performs in routine clinical use.
McMaster Children’s Hospital Serves a Much Larger Region Than Hamilton
McMaster Children’s Hospital is a major referral centre for specialized pediatric care across south-central Ontario. Its oncology program sees approximately 65 newly diagnosed cancer patients annually and manages more than 8,000 pediatric oncology outpatient visits each year, according to figures released in 2025. These visits include ongoing treatment and follow-up appointments rather than representing 8,000 individual cancer patients. The hospital also operates a specialized inpatient hematology and oncology unit that provides chemotherapy, immunotherapy, symptom management, and other services requiring overnight admission.
The hospital’s responsibilities extend from the initial diagnosis through treatment, recovery, and long-term survivorship. Its outpatient oncology services include diagnostic investigations, chemotherapy, supportive care, and assistance for families managing treatment-related complications. Dedicated AfterCare services also help survivors address potential long-term health effects and challenges involving education, employment, and emotional well-being. Hamilton Health Sciences describes the broader hospital as a regional pediatric care hub serving approximately 2.3 million people. This wide catchment area helps explain why investment in diagnostic technology matters beyond Hamilton itself. A family travelling from another community for specialized cancer care may need repeated appointments over many months. Improving imaging capacity at a regional centre could make some of those appointments more efficient while supporting the medical teams responsible for monitoring children throughout their treatment journeys.
The Handprint Ceremony Celebrated Children’s Strength and Resilience
Hyundai’s contribution was marked by a Handprint Ceremony at McMaster Children’s Hospital, continuing a tradition that has become central to the Hope on Wheels initiative. During these events, children affected by cancer place colourful painted handprints on a Hyundai vehicle. The decorated vehicle travels through different communities, creating a visible reminder of the young patients and families behind the fundraising campaign. Bennett participated in the Hamilton event alongside his mother and brother, sharing the personal experience that helped inspire the donation.
The ceremony also brought attention to the doctors, nurses, researchers, and caregivers who support children throughout cancer treatment. For participating families, the experience offers an opportunity to celebrate difficult milestones and recognize the strength required to manage a serious diagnosis. A child’s handprint can represent completing chemotherapy, returning to school, or reaching another meaningful point in recovery. Although the event does not directly change medical treatment, it helps connect the broader community with an illness that can otherwise remain largely invisible outside hospital settings. Hyundai describes the handprint as a symbol of each child’s individual journey, reinforcing the message that pediatric cancer fundraising involves real families rather than abstract medical statistics.
Hyundai’s 225 Canadian Dealerships Help Finance the National Program
A defining feature of Hyundai Hope on Wheels is the participation of the manufacturer’s Canadian dealership network. According to Hyundai’s October 2026 announcement, the initiative is supported by 225 dealerships nationwide. The funding arrangement connects vehicle sales with charitable giving: a portion of every new Hyundai vehicle sold in Canada contributes to Hope on Wheels. The program operates with support from Hyundai Auto Canada and participating retailers, turning an established national sales network into a recurring source of funding for pediatric cancer care and research.
This arrangement distinguishes the initiative from an isolated corporate donation. Instead of depending entirely on occasional fundraising events, the organization receives financial support connected to the manufacturer’s ongoing Canadian vehicle business. Hyundai has not disclosed a specific dollar amount contributed from each new vehicle sold, and the $100,000 Hamilton donation should not be interpreted as an equal contribution from every dealership. The national network provides a foundation for grants to hospitals serving different regions. For individual dealerships, participation also offers an opportunity to strengthen relationships with local health-care organizations and families. The arrangement demonstrates how a business with locations across the country can coordinate contributions toward a shared charitable objective while supporting medical institutions with different funding needs.
The Hamilton Donation Builds on Hyundai’s First Year of Canadian Fundraising
Hyundai Hope on Wheels began in the United States in 1998 before expanding into Canada in February 2025. The Canadian launch included an initial commitment exceeding $4 million for pediatric oncology institutions nationwide, supported by Hyundai Auto Canada and its dealership network. Major early contributions included $1-million grants to Toronto’s Hospital for Sick Children and Montreal’s CHU Sainte-Justine. Those investments established the organization’s emphasis on combining cancer research, patient care, and programs that support survivors and their families.
Hamilton was also part of that inaugural effort. On October 28, 2025, Hyundai Hope on Wheels announced a separate $100,000 donation to Hamilton Health Sciences Foundation and MacKids. That contribution supported pediatric oncology programs, including services addressing the longer-term effects of childhood cancer. The latest 2026 donation therefore represents renewed support for the same hospital, but with a more specifically identified destination: the planned Alpha PCCT imaging system. The distinction demonstrates how funding priorities can evolve as hospitals identify new equipment and treatment needs. While the earlier contribution supported broader oncology services, the new donation is intended to help modernize diagnostic technology. Together, the two announcements represent $200,000 in reported Hyundai Hope on Wheels commitments to pediatric cancer care at McMaster Children’s Hospital over two consecutive years.
Hyundai’s $4.1-Million Canadian Campaign Is Reaching Hospitals Nationwide
The Hamilton donation forms part of a much larger national fundraising effort. Hyundai Hope on Wheels has committed more than $4.1 million toward Canadian pediatric cancer care, research, and family support programs in 2026. Its second annual cross-country tour is distributing funding to health foundations in 15 Canadian cities, according to the October 14 announcement. Earlier stops included London, Ontario, where $100,000 was directed toward a new children’s hospital wing intended to bring pediatric oncology and related research services closer together. Kingston and Ottawa also received separate $100,000 contributions for pediatric cancer programs.
Other parts of the country have benefited from the campaign. British Columbia received a combined $350,000 in announced support during an August event, including funding connected to research through the C17 Council. In October, foundations in Sherbrooke and Montreal received $100,000 each. The different projects demonstrate that hospitals have varying priorities, ranging from diagnostic equipment to research infrastructure and family assistance. Following the Hamilton event, Hyundai announced three remaining Handprint Ceremonies for 2026: Toronto on October 19, Quebec City on October 22, and Montreal on October 23. Those events are scheduled rather than completed as of October 15. Their significance lies in the national reach of a program designed to connect local charitable contributions with a coordinated effort to improve childhood cancer care throughout Canada.
Advanced Imaging and Pediatric Research Could Shape the Next Generation of Care
The need for continued investment is reflected in Canada’s childhood cancer statistics. Public Health Agency of Canada research published in 2025 found that approximately 925 to 1,000 children younger than 15 are diagnosed with cancer annually. Five-year survival has improved to approximately 86%, but many survivors require long-term monitoring for complications related to their illness or treatment. These realities explain why advances in diagnostic equipment, research, and follow-up care remain important even as survival outcomes improve. For a family whose child needs repeated imaging examinations, technology capable of maintaining diagnostic accuracy while reducing radiation exposure could have lasting value.
Hyundai is also supporting research through a partnership with Canada’s C17 Council, which represents 16 specialized academic pediatric hematology and oncology programs across 17 centres. The partnership includes a $1-million research fund supporting four Canadian-led projects, each eligible for $250,000 over two years. This funding complements local hospital contributions by supporting scientific investigations that may improve future treatment options. In Hamilton, the immediate priority is helping McMaster Children’s Hospital acquire its proposed imaging system, with spring 2027 identified as the target installation period. Whether that timeline is achieved will depend on fundraising, procurement, and operational readiness. The promised medical benefits must also be assessed through clinical experience rather than assumed in advance. Still, Hyundai’s latest contribution represents a concrete investment in the equipment and expertise that children facing cancer may depend on for years to come.
